InvestorsHub Logo
Followers 77
Posts 2522
Boards Moderated 1
Alias Born 12/04/2020

Re: None

Wednesday, 09/29/2021 10:41:04 PM

Wednesday, September 29, 2021 10:41:04 PM

Post# of 36589
Revive fumbled the ball by not getting their Buc phase 3 up and running fast enough. They could have had it up and going by September 2020, with results by end of 2020 or early 2021. But they took too long getting the clinical sites up and running and didn't recruit participants hard/fast enough.

By sheer luck, new variants and people reluctant to get the vaccines have given them another chance. But they have to HURRY. THE. FU#K. UP.

It is ridiculous in a global pandemic, with dozens of test sites, and having been invited to phase 3 over year ago, that Revive still doesn't have 600 participants treated.

Again ... they have to HURRY. THE. FU#K. UP.

They will not get a third chance. Big pharma is about to have several oral meds for Covid on the market. We all know they somehow skip clinical trials, giving out duffel bags of cash behind closed doors to speed things along.

Hey, Michael Frank ... HURRY. THE. FU#K. UP.

JACK'S RULES OF TRADING
1. Never chase a stock that's already run up considerably.
2. Never panic sell. In other words: When in doubt, hold.
3. When the stock price is down but the company still has potential, add.